Rennova Health Signs Agreement with Academy Medical to Provide Laboratory Services to U.S. Federal Government Customers

Download as PDF

Includes All Federal Government Facilities Including VA Hospitals

WEST PALM BEACH, Fla.-- Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces the signing of a contract with Academy Medical, LLC, a Service-Disabled Veteran-Owned Small Business, to promote the sale of services to the United States federal government. Academy has substantial experience in establishing, operating and maintaining effective sales channels, contract vehicles and business protocols, with a principal focus on federal government customers of medical services and supplies.

This agreement confirms Rennova’s Riviera Beach Laboratory’s appointment as its exclusive federal government business channel partner to provide for the sale of the services to federal government customers, including U.S. Department of Veterans Affairs, U.S. Department of Defense and U.S. Health and Human Services facilities, among others, as well as non-government and commercial institutional customers.

“The signing of this contract with Academy Medical is an excellent step forward for Rennova Health, as it opens up an important, very large market for our testing services,” said Seamus Lagan, chief executive officer of Rennova Health. “In particular, we look forward to providing not only a broad panel of traditional tests, but also key pharmacogenomics tests. A growing number of pharmaceutical products contain guidance for pharmacogenetics biomarker testing in their labels, and the Department of Veterans Affairs in particular has shown an increased awareness of the utility of this type of testing. Importantly, this agreement with Academy Medical, while providing for a substantial broadening of the market for our laboratory tests, also provides for a reliable payment mechanism,” added Mr. Lagan.

“We are excited to partner with Rennova Health for laboratory tests within U.S. federal government facilities,” said Edward Desser, Chief Executive Officer of Academy Medical. “In addition to Rennova being able to provide a full complement of diagnostics, we were impressed by the company’s strict compliance procedures. We look forward to a mutually productive relationship.”

About Academy Medical, LLC

Academy Medical is a certified Service-Disabled Veteran-Owned Small Business specializing in providing innovative orthopedic implants, allograft tissue, wound care products and other medical devices. As healthcare needs change, Academy Medical prides itself on being a leading edge provider with its ability to adapt and engage with both healthcare professionals and facilities to provide solutions to the many challenges the healthcare sector faces. Academy Medical is a nationwide supplier to Department of Veteran Affairs and Department of Defense hospitals, Indian Health Service clinics and other governmental health facilities. Academy Medical, based in West Palm Beach, Fla., also serves civilian hospitals throughout Florida, and in select markets nationwide. For more information about Academy Medical, LLC. please visit www.academymedical.net

About Rennova Health, Inc.

Rennova Health, Inc. (NASDAQ: RNVA) provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcome. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information about Rennova Health, Inc., visit www.rennovahealth.com.

Rennova Health Safe Harbor Statement

This press release includes forward-looking statements about Rennova Health’s anticipated results that involve risks and uncertainties, including statements regarding our expectations with respect to the completion of our proposed public offering and the gross proceeds from the offering. These statements are subject to significant risks and uncertainties, actual results could differ materially from those projected and Rennova Health cautions investors not to place undue reliance on the forward-looking statements contained in this release. There can be no assurance that Rennova Health will be able to complete the offering on the anticipated terms, or at all. Risks and uncertainties relating to Rennova Health and this offering can be found in the “Risk Factors” section of the preliminary prospectus and final prospectus related to such proposed offering to be filed with the SEC. Rennova Health undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

Rennova Health
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com
or
Investors
LHA
Kim Golodetz, 212-838-3777
Kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
Bvoss@lhai.com

Source: Rennova Health, Inc.

Released August 11, 2016